Cas no 7179-96-6 (methyl[(oxan-2-yl)methyl]amine)

Methyl[(oxan-2-yl)methyl]amine is a secondary amine featuring a tetrahydro-2H-pyran (oxane) substituent, offering a balance of reactivity and stability due to its heterocyclic structure. The compound’s oxane ring enhances solubility in polar organic solvents, while the methylamine moiety provides nucleophilic character, making it useful in reductive amination and other synthetic transformations. Its moderate basicity and steric profile allow for selective reactivity in pharmaceutical and agrochemical intermediates. The compound’s stability under mild conditions ensures compatibility with diverse reaction environments. Suitable for use in fine chemical synthesis, it serves as a versatile building block for functionalized amine derivatives.
methyl[(oxan-2-yl)methyl]amine structure
7179-96-6 structure
Product Name:methyl[(oxan-2-yl)methyl]amine
CAS No:7179-96-6
MF:C7H15NO
MW:129.200102090836
MDL:MFCD06738978
CID:976728
PubChem ID:12700142
Update Time:2025-10-23

methyl[(oxan-2-yl)methyl]amine Chemical and Physical Properties

Names and Identifiers

    • N-Methyl-1-(tetrahydro-2H-pyran-2-yl)methanamine
    • Methyl-(tetrahydro-pyran-2-ylmethyl)amine
    • methyl-(tetrahydro-pyran-2-ylmethyl)-amine
    • N-methyl-1-(oxan-2-yl)methanamine
    • 2-Methylaminomethyltetrahydropyran
    • methyl(oxan-2-ylmethyl)amine
    • N-methyl-1-(2-oxanyl)methanamine
    • methyl[(oxan-2-yl)methyl]amine
    • F16332
    • 7179-96-6
    • SCHEMBL2128830
    • FT-0683566
    • A837333
    • F8889-8163
    • AS-47837
    • PMULDAJCNKLGCN-UHFFFAOYSA-N
    • AKOS005169891
    • (+/-)-N-(1-tetrahydro-2H-pyran-2-ylmethyl)-N-methylamine
    • 2H-Pyran-2-methanamine, tetrahydro-N-methyl-
    • methyl-(tetrahydro-pyran-2-ylmethyl)-amine, AldrichCPR
    • EN300-51941
    • (+/-)-N-(1-tetrahydro-2H-pyran-2-ylmethyl) -N-methylamine
    • N-methyl-1-tetrahydropyran-2-yl-methanamine
    • MFCD06738978
    • DTXSID80507340
    • DB-013497
    • methyl(tetrahydro-2H-pyran-2-ylmethyl)amine
    • ALBB-012353
    • MDL: MFCD06738978
    • Inchi: 1S/C7H15NO/c1-8-6-7-4-2-3-5-9-7/h7-8H,2-6H2,1H3
    • InChI Key: PMULDAJCNKLGCN-UHFFFAOYSA-N
    • SMILES: O1CCCCC1CNC

Computed Properties

  • Exact Mass: 129.11500
  • Monoisotopic Mass: 129.115364102g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 2
  • Heavy Atom Count: 9
  • Rotatable Bond Count: 2
  • Complexity: 75.3
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 1
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 0.6
  • Topological Polar Surface Area: 21.3?2

Experimental Properties

  • Density: 0.9±0.1 g/cm3
  • Boiling Point: 179.8±13.0 °C at 760 mmHg
  • Flash Point: 65.1±9.3 °C
  • Refractive Index: 1.435
  • PSA: 21.26000
  • LogP: 1.16580
  • Vapor Pressure: 0.9±0.3 mmHg at 25°C

methyl[(oxan-2-yl)methyl]amine Security Information

methyl[(oxan-2-yl)methyl]amine Customs Data

  • HS CODE:2932999099
  • Customs Data:

    China Customs Code:

    2932999099

    Overview:

    2932999099. Other heterocyclic compounds containing only oxygen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%

    Declaration elements:

    Product Name, component content, use to

    Summary:

    2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

methyl[(oxan-2-yl)methyl]amine Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Alichem
A119001577-1g
N-Methyl-1-(tetrahydro-2H-pyran-2-yl)methanamine
7179-96-6 95%
1g
$237.60 2023-09-01
Chemenu
CM280884-1g
N-Methyl-1-(tetrahydro-2H-pyran-2-yl)methanamine
7179-96-6 95%
1g
$206 2021-08-18
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
20R0233-1g
Methyl-(tetrahydro-pyran-2-ylmethyl)-amine
7179-96-6 96%
1g
1679.12CNY 2021-05-08
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
20R0233-5g
Methyl-(tetrahydro-pyran-2-ylmethyl)-amine
7179-96-6 96%
5g
5919.34CNY 2021-05-08
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
20R0233-25g
Methyl-(tetrahydro-pyran-2-ylmethyl)-amine
7179-96-6 96%
25g
23490.77CNY 2021-05-08
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
20R0233-500mg
Methyl-(tetrahydro-pyran-2-ylmethyl)-amine
7179-96-6 96%
500mg
1263.58CNY 2021-05-08
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
20R0233-250mg
Methyl-(tetrahydro-pyran-2-ylmethyl)-amine
7179-96-6 96%
250mg
1060.05CNY 2021-05-08
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
20R0233-100mg
Methyl-(tetrahydro-pyran-2-ylmethyl)-amine
7179-96-6 96%
100mg
932.85CNY 2021-05-08
TRC
M219280-25mg
N-Methyl-1-(tetrahydro-2H-pyran-2-yl)methanamine
7179-96-6
25mg
$ 50.00 2022-06-04
TRC
M219280-50mg
N-Methyl-1-(tetrahydro-2H-pyran-2-yl)methanamine
7179-96-6
50mg
$ 65.00 2022-06-04

Additional information on methyl[(oxan-2-yl)methyl]amine

Comprehensive Overview of Methyl[(oxan-2-yl)methyl]amine (CAS No. 7179-96-6): Properties, Applications, and Industry Insights

Methyl[(oxan-2-yl)methyl]amine (CAS No. 7179-96-6) is a specialized organic compound gaining attention in pharmaceutical and agrochemical research due to its unique structural features. This secondary amine, featuring a tetrahydro-2H-pyran (oxane) ring, serves as a versatile building block in synthetic chemistry. Its molecular formula C7H15NO and moderate polarity make it particularly valuable for designing drug candidates with improved bioavailability.

Recent studies highlight the compound's role in chiral synthesis, where the oxane ring contributes to stereochemical control. Researchers are exploring its potential in asymmetric catalysis, especially for producing enantiomerically pure compounds—a hot topic in green chemistry circles. The methylamine moiety allows for straightforward derivatization, making 7179-96-6 a favorite among medicinal chemists developing CNS-active molecules.

From a commercial perspective, methyl[(oxan-2-yl)methyl]amine addresses growing demand for heterocyclic amines in material science. Its thermal stability (decomposition point >200°C) and solubility profile (miscible with common organic solvents) make it suitable for polymer modification applications. Industry reports indicate increasing use in epoxy curing agents and polyurethane catalysts, aligning with trends toward high-performance specialty chemicals.

Analytical characterization of CAS 7179-96-6 typically involves GC-MS (showing characteristic m/z 129 [M+]) and NMR spectroscopyH 2.45 ppm for N-CH3 protons). The compound's logP value of 0.82 suggests balanced lipophilicity, explaining its utility in prodrug design—a frequent search topic among pharmaceutical researchers. Stability studies show excellent resistance to hydrolysis at physiological pH, a property highly valued in drug delivery system development.

Environmental considerations position methyl[(oxan-2-yl)methyl]amine favorably compared to traditional amine compounds. Its biodegradation potential (62% in 28 days per OECD 301D) and low bioaccumulation factor meet stringent REACH compliance requirements. These attributes resonate with current industry focus on sustainable chemistry, as evidenced by rising searches for "eco-friendly amine derivatives" across scientific databases.

Future applications may exploit the compound's hydrogen bonding capacity (donor: 1; acceptor: 2) for supramolecular chemistry applications. Preliminary studies suggest utility in molecular imprinting technologies—an area receiving growing attention in biosensor development. The oxane ring's conformational flexibility could also enable novel enzyme inhibitor designs, particularly for targets requiring allosteric modulation.

Quality specifications for 7179-96-6 typically require ≥97% purity (HPLC), with strict control of residual solvents (methanol <0.1%). Storage recommendations emphasize argon atmosphere protection to prevent oxidative degradation—a critical consideration for users searching "amine stabilization techniques." Leading manufacturers now offer customized salt forms (e.g., hydrochloride) to address formulation challenges in ionizable APIs.

The synthesis of methyl[(oxan-2-yl)methyl]amine typically involves reductive amination of 2-(aminomethyl)tetrahydro-2H-pyran, with recent patents describing improved catalytic hydrogenation methods. Process chemists are particularly interested in continuous flow approaches to enhance yield (>85%) and reduce E-factor—key metrics in process intensification strategies dominating chemical engineering discussions.

Safety data indicates LD50 >2000 mg/kg (oral, rat), classifying the compound as Category 5 under GHS guidelines. Proper handling requires standard amine precautions (ventilation, PPE), with particular attention to its hygroscopic nature—information frequently sought in laboratory safety queries. The compound's flash point of 93°C suggests moderate flammability, requiring DMSO-compatible storage solutions.

Market analysis reveals steady growth (CAGR 4.2%) for N-substituted oxane derivatives, driven by demand in electronic chemicals and lubricant additives. The pharma sector accounts for 62% of current 7179-96-6 consumption, with notable applications in kinase inhibitor scaffolds. Patent landscaping shows increasing activity around tandem reactions utilizing this amine, particularly in multicomponent synthesis methodologies.

Recommended suppliers
Suzhou Senfeida Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Suzhou Senfeida Chemical Co., Ltd
Essenoi Fine Chemical Co., Limited
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Suzhou Genelee Bio-Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Suzhou Genelee Bio-Technology Co., Ltd.
Nanjing Jubai Biopharm
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Nanjing Jubai Biopharm
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.